Favorable response to combination treatment of cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin system inhibitor in metastatic renal cell carcinoma: Report of three cases
Author:
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.2008.02102.x/fullpdf
Reference11 articles.
1. Prognostic factors in metastatic renal cell carcinoma: Metastasectomy as independent prognostic variable;Vogl;Br. J. Cancer,2006
2. Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma;Rini;Cancer,2006
3. Advanced renal cell carcinoma in which a combination of IFN-alpha and meloxicam was thought to be effective;Yoshino;Int. J. Urol,2003
4. Histamine suppression of human lymphocyte responses to mitogens;Wang;Cell. Immunol,1978
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Old wine in new bottles: Drug repurposing in oncology;European Journal of Pharmacology;2020-01
2. Récepteurs de type 1 à l’angiotensine-2 (AT1R) et cancers;Néphrologie & Thérapeutique;2013-04
3. Local renin–angiotensin system and the brain—A continuous quest for knowledge;Peptides;2011-05
4. Cimetidine: An anticancer drug?;European Journal of Pharmaceutical Sciences;2011-04
5. Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?;British Journal of Cancer;2010-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3